Apollo Hospitals leans on complex care and higher utilisation as hospital revenue rises 22% in June quarter
AI مارکیٹ کا خلاصہ
Apollo Hospitals reported strong hospital revenue growth driven primarily by mature facilities and improved utilisation, with higher EBITDA margins offset by losses at newer hospitals. Mix shift toward complex care and rising robotic and transplant volumes suggest structurally higher ARPOB and operational leverage. Planned bed additions and the potential FY27 listing of Apollo HealthCo frame a broader integrated healthcare platform, but the readthrough remains largely idiosyncratic rather than market-wide.
اثر کی سطح
● لو
متاثرہ اثاثے
NCCOGOLD2USD/USDT+0.62%
AI تجزیاتی سمجھ · NCCOGOLD2USD/USDTAI تجزیاتی سمجھ
● Neutral
ابھی ٹریڈ کریں
⚠️ AI سے تیار کردہ تجزیاتی سمجھ خبروں کے مواد پر مبنی ہے اور صرف معلوماتی مقاصد کے لیے فراہم کی گئی ہے۔ یہ سرمایہ کاری کا مشورہ نہیں ہے اور نہ ہی BingX کے خیالات کی نمائندگی کرتی ہے۔ سرمایہ کاری میں رسک شامل ہے۔ براہ کرم ذمہ داری سے ٹریڈ کریں۔
Apollo Hospitals said its hospital business revenue rose 22% year on year in the June quarter, with established hospitals contributing 18 percentage points of growth and new hospitals adding 3 percentage points. EBITDA margin at mature hospitals expanded to 25.9%, while new facilities posted losses of about Rs 37.5 crore for the quarter. Robotic soft-tissue surgeries rose 85% year on year to more than 1,800 procedures, and the company is targeting an annualised revenue run rate of Rs 25,000 crore by the fourth quarter of FY27, according to Moneycontrol.
